Bronchodilator Responsiveness From 14 Countries: Population-based Rates And Correlates From The Burden Of Obstructive Lung Disease (BOLD) Study

Author(s):  
Wan C. Tan ◽  
Michael Studnicka ◽  
David M. Mannino ◽  
Anamika Jithoo ◽  
Paul Enright ◽  
...  
PLoS ONE ◽  
2016 ◽  
Vol 11 (3) ◽  
pp. e0151981 ◽  
Author(s):  
Meriam Denguezli ◽  
Hager Daldoul ◽  
Imed Harrabi ◽  
Louisa Gnatiuc ◽  
Sonia Coton ◽  
...  

Thorax ◽  
2012 ◽  
Vol 67 (8) ◽  
pp. 718-726 ◽  
Author(s):  
Wan C Tan ◽  
William M Vollmer ◽  
Bernd Lamprecht ◽  
David M Mannino ◽  
Anamika Jithoo ◽  
...  

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Marie-Christine Delmas ◽  
Laetitia Bénézet ◽  
Céline Ribet ◽  
Yuriko Iwatsubo ◽  
Marie Zins ◽  
...  

Abstract Background The burden of undiagnosed obstructive lung disease (OLD) (mainly asthma and chronic obstructive pulmonary disease) is not fully established, and targets for corrective action are yet to be identified. We assessed the underdiagnosis of OLD and its determinants in France. Methods CONSTANCES is a French population-based cohort of adults aged 18–69 years at inception. We analysed data collected at inclusion in 2013–2014. Undiagnosed OLD was defined as spirometry-confirmed airflow limitation (FEV1/FVC < lower limit of normal) without prior diagnosis of asthma, chronic obstructive pulmonary disease, or bronchiectasis. Multivariate analysis was performed with weighted robust Poisson regression models to estimate the adjusted prevalence ratios (aPR) of undiagnosed OLD. Results Spirometry results were available for 19,398 participants. The prevalence of airflow limitation was 4.6%. Overall, 64.4% of adults with airflow limitation did not report a previous diagnosis of OLD. Individuals with high cumulative tobacco consumption (≥ 10 pack-years) (aPR: 1.72 [1.28–2.32]), without respiratory symptoms (aPR: 1.51 [1.28–1.78]), and with preserved lung function (aPR: 1.21 [1.04–1.41] for a 10-point increase in FEV1% predicted) had a higher risk of being undiagnosed. Half of symptomatic individuals with airflow limitation (45% of those with moderate to severe airflow limitation) were undiagnosed with OLD. Conclusion Underdiagnosis of OLD is very common among French adults, even in patients with respiratory symptoms. Efforts should be made in France to raise awareness about OLD in the general population, improve the detection of respiratory symptoms, and increase the use of spirometry among primary care professionals.


2013 ◽  
Vol 65 (8) ◽  
pp. 1243-1250 ◽  
Author(s):  
Carlotta Nannini ◽  
Yimy F. Medina-Velasquez ◽  
Sara J. Achenbach ◽  
Cynthia S. Crowson ◽  
Jay H. Ryu ◽  
...  

2011 ◽  
Vol 18 (6) ◽  
pp. 321-326 ◽  
Author(s):  
WC Tan ◽  
J Bourbeau ◽  
P Hernandez ◽  
K Chapman ◽  
R Cowie ◽  
...  

BACKGROUND: Currently, no reference or normative values for spirometry based on a randomly selected Canadian population exist.OBJECTIVE: The aim of the present analysis was to construct spirometric reference values for Canadian adults 20 to 90 years of age by combining data collected from healthy lifelong nonsmokers in two population-based studies.METHOD: Both studies similarly used random population sampling, conducted using validated epidemiological protocols in the Canadian Obstructive Lung Disease study, and the Lung Health Canadian Environment study. Spirometric lung function data were available from 3042 subjects in the COLD study, which was completed in 2009, and from 2571 subjects in the LHCE study completed in 1995. A total of 844 subjects 40 to 90 years of age, and 812 subjects 20 to 44 years of age, were identified as healthy, asymptomatic, lifelong nonsmokers, and provided normative reference values for spirometry. Multiple regression models were constructed separately for Caucasian men and women for the following spirometric parameters: forced expiratory volume in 1 s (FEV1), forced vital capacity (FVC) and FEV1/FVC ratio, with covariates of height, sex and age. Comparison with published regression equations showed that the best agreement was obtained from data derived from random populations.RESULTS: The best-fitting regression models for healthy, never-smoking, asymptomatic European-Canadian men and women 20 to 90 years of age were constructed. When age- and height-corrected FEV1, FVC and FEV1/FVC ratio were compared with other spirometry reference studies, mean values were similar, with the closest being derived from population-based studies.CONCLUSION: These spirometry reference equations, derived from randomly selected population-based cohorts with stringently monitored lung function measurements, provide data currently lacking in Canada.


Sign in / Sign up

Export Citation Format

Share Document